Elastic stable intramedullary nailing versus submuscular plating in length unstable pediatric diaphyseal femur fractures: A prospective comparative study

弹性稳定髓内钉与肌下钢板固定治疗儿童股骨干长度不稳定骨折:一项前瞻性比较研究

阅读:1

Abstract

OBJECTIVE: This study aims to compare the effectiveness of ESIN versus SMPs in both length-stable and unstable fractures of the femoral diaphysis in children above five years of age. METHODS: A Prospective Comparative Study was done including 40 children aged 5-13 years with a displaced shaft of femur fracture. Patients were randomized with either elastic nailing or submuscular plating as one of the operating options and were operated on according to their unique hospital identification number. The mean blood loss, operative time, fluoroscopy time, duration of analgesic use, and complications in both groups were noted. At end of 12 months, the primary outcome as per Flynn's criteria, was evaluated. Minimum 2 year follow up was done to evaluate for any complications. RESULTS: 40 patients were available for the study, 22 in ESIN (group1) and 18 in SMP (group2). In the ESIN (group1), 16 patients (72.72 %) had excellent grade, 4 patients (18.18 %) had satisfactory grade, and 2 patients (9.09 %) had a poor grade. In the SMP group, 17patients (94.44 %) had excellent grade, and 1 patient (5.55 %) had a poor outcome. Surgical parameters such as the mean operative time, incision length, blood loss, mean fluoroscopy time was significantly shorter in ESIN group compared to the SMP group (<0.001). CONCLUSIONS: The outcome of fractures, irrespective of length stability managed by ESIN are comparable to SMP. Based on our findings, ESIN can safely be employed for management of length unstable fractures. The choice of implant should be based on surgeon's discretion, comfort level, patient decision and overall cost of the procedure, rather than on length stability of fracture.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。